Metropolis Healthcare Q2 Results: Profit Jumps 31%, Meets Estimates
Ebitda margin expands to 25.7% from 24.2% in the year-ago period.
Metropolis Healthcare Ltd.'s consolidated net profit rose 31% in the second quarter of the financial year, meeting analysts' estimates.
The diagnostic service provider's profit stood at Rs 46.7 crore in the quarter ended September, compared with Rs 35.7 crore in the same period in the previous fiscal, according to an exchange filing on Friday. The consensus estimate of analysts tracked by Bloomberg stood at Rs 47 crore.
Metropolis Q2 FY25 Highlights (Consolidated, YoY)
Revenue up 13% to Rs 350 crore (Bloomberg estimate: Rs 350 crore).
Ebitda up 32% to Rs 89.9 crore (Estimate: Rs 90 crore).
Ebitda margin expands to 25.7% from 24.2% (Estimate: 25.8%).
Net profit up 31% to Rs 46.7 crore (Bloomberg estimate: Rs 47 crore).
Shares of Metropolis Healthcare closed 0.17% higher at Rs 2,115.45 apiece on the NSE, compared to a 0.21% fall in the benchmark Nifty 50.
(This is a developing story)
